“The Global Fetal & Neonatal Care Equipment market is estimated to be worth $8.3bn in 2023” says new Visiongain report05 October 2018Pharma
Fetal and neonatal care are emerging as a vital aspect in medical healthcare industry.
“The Global Pharmaceutical Wholesale & Distribution market is estimated to be worth $1.3bn in 2023” says new Visiongain report03 October 2018Pharma
Growth in the global pharmaceutical wholesale and distribution market has remained steady in recent years.
“The Global Pharmaceutical Contract Manufacturing market is estimated to grow at a CAGR of 6% in the first-half of the forecast period” says Visiongain report01 October 2018Pharma
Contract manufacturing represents the largest sector of the pharma outsourcing industry.
“Global Next-Generation Antibody Therapies market set to grow to $17bn by 2023” says new Visiongain report25 September 2018Pharma
Next-generation antibody therapies are becoming established treatments for haematological malignancies and solid tumours (phase 3) pipelines are relatively sparse, however, with most pipeline candidates in phase 1 or phase 2 of development.
21 September 2018Pharma
Acute myeloid leukaemia (AML) is the most common acute leukaemia in adults and among the most lethal. In the United States, the annual incidence of AML is 19 000 new cases, and the incidence of AML-associated deaths is 10 000.